May 5, 2023
Ken Cusi and Roger Green are joined by Diana Barb and Jay Shubrook in a discussion around effective therapies and strategies for fighting fatty liver disease that are available now. The group discusses frontline screening, medications, bariatric surgery, lifestyle management, practical insights and much more.
Every week, a global community of Fatty Liver Disease stakeholders comes together to explore the most important challenges in diagnosing, treating, and developing medications for patients with Fatty Liver Diseases.
Join hepatology researcher and Key Opinion Leader Dr. Stephen Harrison, liver wellness advocate Louise Campbell MSc AP., Forecasting and Pricing guru Roger Green, M.B.A., and their weekly guests as they discuss these issues from their own unique perspectives on the Surfing the NASH Tsunami podcast.
The episode celebrates and reflects on International #NASHDay 2023 with a panel of patient advocates (Michael Betel, Gina Villiotti Madison and Marko Korenjak) and co-hosts Louise Campbell and Roger Green. Each speaks to what the day means to them and the group explores how the community is taking action to step up to a public health epidemic.
Last author and leading endocrinology Fatty Liver Opinion Leader Ken Cusi joins co-author Stephen Harrison, Louise Campbell and Roger Green to discuss the recent Clinical Care Pathway published in Gastroenterology. This conversation From the Vault answers the question “What Can Be Done Today?” in terms of screening and patient management without approved drugs.
Cyrielle Caussy and the Surfers explore final thoughts on identifying NAFLD/NASH patients earlier on in endocrinology settings and the role of allied health professionals in making this possible. Finally, each panelist is asked what they would do if they had a magic wand to touch one thing in their hospital to make a change.
Cyrielle Caussy and the Surfers explore the strength of simple tools that closely link consequence to physicians and push for the identification and risk stratification of respective patient populations. This session also entertains with a fascinating anecdote on the famous composer, Beethoven, and his liver health.
Cyrielle Caussy joins the Surfers to talk about how patients can be motivated by biofeedback to improve both liver health and overall condition. Following, the group discusses how specific phenotypes in chronic kidney patients can be targeted for high risk of NAFLD/NASH.
In continuing conversation around clinical care pathways and the complex of metabolic diseases, SurfingNASH explores the key relationship and interplay between endocrinology and hepatology. This conversation features Cyrielle Caussy alongside Surfers Jörn Schattenberg, Louise Campbell and Roger Green discussing why endocrinology clinics are a critical setting for early identification of patients with NAFLD and NASH.
In continuing conversation around clinical care pathways and the complex of metabolic diseases, SurfingNASH explores the key relationship and interplay between endocrinology and hepatology. Jörn Schattenberg, Louise Campbell and Roger Green are joined by Cyrielle Caussy to discuss interprofessional collaboration, education and awareness on Fatty Liver disease and early identification of at-risk populations.